pubmed-article:21195613 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21195613 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:21195613 | lifeskim:mentions | umls-concept:C0220806 | lld:lifeskim |
pubmed-article:21195613 | lifeskim:mentions | umls-concept:C0084178 | lld:lifeskim |
pubmed-article:21195613 | lifeskim:mentions | umls-concept:C0002483 | lld:lifeskim |
pubmed-article:21195613 | lifeskim:mentions | umls-concept:C0242210 | lld:lifeskim |
pubmed-article:21195613 | lifeskim:mentions | umls-concept:C1510827 | lld:lifeskim |
pubmed-article:21195613 | lifeskim:mentions | umls-concept:C0205198 | lld:lifeskim |
pubmed-article:21195613 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21195613 | pubmed:dateCreated | 2011-1-11 | lld:pubmed |
pubmed-article:21195613 | pubmed:abstractText | In order to identify the binding proteins to anti-resorptive 5-chloro-1-(2,6-dimethylpiperidin-1-yl)-N-tosylpentan-1-imine (1), the chemical affinity matrix for the compound 1 (2b) was designed and synthesized. Using 2b-based chemical proteomics, prohibitin was identified as one of strong binding proteins for 2b. | lld:pubmed |
pubmed-article:21195613 | pubmed:language | eng | lld:pubmed |
pubmed-article:21195613 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195613 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21195613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195613 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21195613 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21195613 | pubmed:month | Jan | lld:pubmed |
pubmed-article:21195613 | pubmed:issn | 1464-3405 | lld:pubmed |
pubmed-article:21195613 | pubmed:author | pubmed-author:ChangSukbokS | lld:pubmed |
pubmed-article:21195613 | pubmed:author | pubmed-author:BaekSeung-Hwa... | lld:pubmed |
pubmed-article:21195613 | pubmed:author | pubmed-author:KimSeong... | lld:pubmed |
pubmed-article:21195613 | pubmed:author | pubmed-author:ChangSung-You... | lld:pubmed |
pubmed-article:21195613 | pubmed:author | pubmed-author:LeeMyung... | lld:pubmed |
pubmed-article:21195613 | pubmed:author | pubmed-author:BaeSu JungSJ | lld:pubmed |
pubmed-article:21195613 | pubmed:copyrightInfo | Copyright © 2010 Elsevier Ltd. All rights reserved. | lld:pubmed |
pubmed-article:21195613 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21195613 | pubmed:day | 15 | lld:pubmed |
pubmed-article:21195613 | pubmed:volume | 21 | lld:pubmed |
pubmed-article:21195613 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21195613 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21195613 | pubmed:pagination | 727-9 | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:meshHeading | pubmed-meshheading:21195613... | lld:pubmed |
pubmed-article:21195613 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21195613 | pubmed:articleTitle | Chemical affinity matrix-based identification of prohibitin as a binding protein to anti-resorptive sulfonyl amidine compounds. | lld:pubmed |
pubmed-article:21195613 | pubmed:affiliation | Medicinal Chemistry Research Center, Korea Research Institute of Chemical Technology, PO Box 107, Yuseong-gu, Daejeon 305-600, Republic of Korea. | lld:pubmed |
pubmed-article:21195613 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21195613 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |